The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
ID 22684 | 07.10.2024 / In allegato
An Overview of Risk Assessment Methods, Selected Case Studies and Available Software
The 1992 United N...
ID 20221 | 22.08.2023 / In allegato Documento completo
Pubblicato nella GU L 191/1 del 28 luglio 2023 il Regolamento (UE) 2023/1542 de...
Regolamento (UE) 2021/862 della Commissione del 28 maggio 2021 che modifica il regolamento (CE) n. 2003/2003 del Parlamento europeo e del Consiglio relativo ai concimi allo sc...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
